1. Wu, Mingfu, Li, Jing, Gao, Qinglei, Ye, Fei. 2016. The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases. In Expert opinion on therapeutic targets, 20, 885-901. doi:10.1517/14728222.2016.1139083. https://pubmed.ncbi.nlm.nih.gov/26732941/
2. Huang, Jiaxing, Wang, Xiaotang, Li, Na, Yang, Peizeng, Hou, Shengping. 2024. YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2308031. doi:10.1002/advs.202308031. https://pubmed.ncbi.nlm.nih.gov/38493498/
3. Yukawa, Kazunori, Tanaka, Tetsuji, Kishino, Masanori, Kikutani, Hitoshi, Kumanogoh, Atsushi. . Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. In International journal of molecular medicine, 26, 39-44. doi:. https://pubmed.ncbi.nlm.nih.gov/20514420/
4. Zhu, Zhenlai, Luo, Yang, Yu, Jinlei, Yao, Xu, Li, Wei. 2016. Sema4D is required in both the adaptive and innate immune responses of contact hypersensitivity. In Molecular immunology, 78, 98-104. doi:10.1016/j.molimm.2016.09.003. https://pubmed.ncbi.nlm.nih.gov/27614265/
5. Cui, Kaixuan, Tang, Xiaoyu, Yang, Boyu, Xu, Yue, Liang, Xiaoling. . Sema4D Knockout Attenuates Choroidal Neovascularization by Inhibiting M2 Macrophage Polarization Via Regulation of the RhoA/ROCK Pathway. In Investigative ophthalmology & visual science, 65, 34. doi:10.1167/iovs.65.6.34. https://pubmed.ncbi.nlm.nih.gov/38913005/
6. Feigin, Andrew, Evans, Elizabeth E, Fisher, Terrence L, Kieburtz, Karl D, Zauderer, Maurice. 2022. Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial. In Nature medicine, 28, 2183-2193. doi:10.1038/s41591-022-01919-8. https://pubmed.ncbi.nlm.nih.gov/35941373/
7. Rezaeepoor, Mahsa, Rashidi, Golnaz, Pourjafar, Mona, Solgi, Ghasem, Najafi, Rezvan. 2021. SEMA4D Knockdown Attenuates β-Catenin-Dependent Tumor Progression in Colorectal Cancer. In BioMed research international, 2021, 8507373. doi:10.1155/2021/8507373. https://pubmed.ncbi.nlm.nih.gov/34337054/
8. Smanio Neto, Henrique, Moy, Peter Karyen, Martinez, Elizabeth Ferreira, Clemente-Napimoga, Juliana Trindade, Napimoga, Marcelo Henrique. 2023. Sema4D is diminished in leukocyte platelet-rich fibrin and impairs pre-osteoblastic MC3T3-E1 cells' functionality. In Archives of oral biology, 155, 105778. doi:10.1016/j.archoralbio.2023.105778. https://pubmed.ncbi.nlm.nih.gov/37572522/
9. Zhang, Hong-Lei, Wang, Jing, Tang, Long. . Sema4D knockdown in oligodendrocytes promotes functional recovery after spinal cord injury. In Cell biochemistry and biophysics, 68, 489-96. doi:10.1007/s12013-013-9727-0. https://pubmed.ncbi.nlm.nih.gov/23949850/
智鼠故事 
